Thermo Fisher Scientific Inc. (TMO): Among Billionaire Quants' Two Sigma's Stock Picks with Huge Upside Potential
is one of the leading players in the quantitative hedge fund space, according to Archive Market Research's analysis. The quant fund operates as an investment management company and was founded in 2001 by David Siegel, a computer scientist, and John Overdeck, a mathematician. The fund manages $60 billion worth of assets as of April 2025.
Quant funds and their multi-strategy counterparts often do well in the market. A Reuters analysis found that many quant hedge funds posted double-digit growth in 2024. This growth happened despite 'negative drivers' in sectors like energy, metals, and European equities. Two Sigma, alongside quant funds like D.E. Shaw and Citadel, also managed solid performance last year.
The hedge fund's Spectrum Fund returned 10.9% and 14.3% for the Absolute Return Enhanced Fund. But one might argue that for a hedge fund that relies on complex algorithms to make investment decisions, the asset manager should have beat the market. For context, the S&P 500 finished 2024 with a total gain of 25.0%.
READ ALSO: Billionaire Ray Dalio's Bridgewater's 10 Stock Picks with Huge Upside Potential and Billionaire Mario Gabelli's 10 Large-Cap Stock Picks with Huge Upside Potential.
In August last year, the billionaire founders of the hedge fund exited from active management because they couldn't resolve tension between them.
'Over the past year and a half, we and our senior management team have dedicated significant effort to securing the long-term success and stability of Two Sigma. Throughout this process, our own roles have been a central consideration. Today, we are confident that stepping back from our day-to-day management roles is the right decision at this time,' the co-founders said in a letter to investors.
But recent reports indicate that Overdeck is returning to active management. 'John has determined now is the right time for him to return to this role in order to progress certain priorities and decisions he believes are important to the future of Two Sigma,' Two Sigma said in a letter. Siegel chose to remain outside of the fund's top ranks but had 'full confidence' in Scott Hoffman, one of the Co-CEOs who took over last year.
It is good news that Two Sigma won't be held back by feuding management because they need it to navigate a challenging market. According to a Reuters analysis, the risk of recession is alarming, even though it may not be as clear-cut. The report quoted Zurich Insurance Group's chief market strategist, Guy Miller, who said that the risk of a US recession is quite plausible. 'Recession risks have risen markedly even if there are some deals struck on tariffs. The risk of a U.S. recession is 50-50, it's that close.'
We sifted through Two Sigma Advisors' SEC Q4 2024 13F filings to create this list. We primarily targeted the fund's most valuable equity holdings (excluding ETFs and options) and then ranked the picks based on analyst price targets as of May 8, 2025. We picked stocks with an upside potential of at least 30% and then selected the top 10. We have also added the broader hedge fund sentiment for the stocks, as of Q4 2024.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points ().
A workstation in a research lab stocked with laboratory products and services.Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader in scientific research and laboratory solutions. It provides tools, technologies, and services to help scientists, healthcare professionals, and businesses advance discoveries and improve lives.
The company has recently made several moves to strengthen its market position. On April 24, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) announced a $2 billion investment in the US over the next four years. The first $1.5 billion will be allocated to capital expenditures for enhancing and expanding US manufacturing operations, and $500 million will go to R&D focused on high-impact innovation. This investment builds on the company's substantial presence in US manufacturing, which already includes 64 operations across 37 states. On April 28, 2025, Thermo Fisher Scientific Inc. (NYSE:TMO) introduced an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months. The solution helps biotech and pharmaceutical companies overcome logistical complexities in pre-clinical biologic drug development.
The company has also taken some cost-cutting measures. On May 3, 2025, Thermo Fisher (NYSE:TMO) announced it would close its location near downtown Orlando and lay off 58 employees. The move will primarily affect researchers, nurses, and staff tied to its PPD Clinical Research Services division. On April 25, Scotiabank analyst Sung Ji Nam adjusted the price target for Thermo Fisher Scientific Inc. (NYSE:TMO) to $605 from $650. Nam wrote that although the company surpassed expectations in its first quarter results of 2025, it revised the full-year guidance. Nevertheless, Nam maintained a Sector Perform rating.
Overall, TMO ranks 5th on our list of billionaire quants' two sigma's stock picks with huge upside potential. While we acknowledge the potential of TMO as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than TMO but that trades at less than 5 times its earnings check out our report about this
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
IDEX Corporation Just Beat EPS By 5.8%: Here's What Analysts Think Will Happen Next
It's been a mediocre week for IDEX Corporation (NYSE:IEX) shareholders, with the stock dropping 14% to US$159 in the week since its latest second-quarter results. The result was positive overall - although revenues of US$865m were in line with what the analysts predicted, IDEX surprised by delivering a statutory profit of US$1.74 per share, modestly greater than expected. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Taking into account the latest results, the current consensus from IDEX's twelve analysts is for revenues of US$3.43b in 2025. This would reflect an okay 2.8% increase on its revenue over the past 12 months. Statutory per share are forecast to be US$6.25, approximately in line with the last 12 months. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$3.44b and earnings per share (EPS) of US$6.70 in 2025. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts. Check out our latest analysis for IDEX The consensus price target held steady at US$201, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. Currently, the most bullish analyst values IDEX at US$225 per share, while the most bearish prices it at US$170. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth. Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that IDEX's revenue growth will slow down substantially, with revenues to the end of 2025 expected to display 5.7% growth on an annualised basis. This is compared to a historical growth rate of 7.3% over the past five years. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 4.3% per year. So it's pretty clear that, while IDEX's revenue growth is expected to slow, it's still expected to grow faster than the industry itself. The Bottom Line The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for IDEX. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. The consensus price target held steady at US$201, with the latest estimates not enough to have an impact on their price targets. Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have forecasts for IDEX going out to 2027, and you can see them free on our platform here. It might also be worth considering whether IDEX's debt load is appropriate, using our debt analysis tools on the Simply Wall St platform, here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
32 minutes ago
- USA Today
XRP is the smartest cryptocurrency to buy with $500 right now
XRP is demonstrating its long-term growth potential. Nowadays, $500 doesn't feel like much — especially if you invest it in the S&P 500 index, where you can expect to make an average annual return of 10% (assuming historical trends remain constant). That's just $50 per year. However, the cryptocurrency industry offers the potential for significantly larger gains than traditional asset classes, like stocks or bonds, for investors who are willing to tolerate more volatility. Below I'll explore why the payments-focused token digital XRP (CRYPTO: XRP) might make an excellent long-term pick as it racks up regulatory wins in the U.S. and seeks to disrupt the market for international transactions. The regulatory climate is easing Donald Trump's presidential election victory sparked a sharp rally in many cryptocurrencies, and it isn't hard to understand why Wall Street is so optimistic. On the campaign trail, he promised to support the digital asset industry and, so far, his administration is meeting or even exceeding expectations with a raft of newly passed legislation. On July 18, Trump signed the Guiding and Establishing National Innovation for US Stablecoins (Genius) Act, which is designed to create a framework for issuing dollar-pegged stablecoins. On its face, this law helps legitimize cryptocurrency as a mainstream asset class, which will encourage businesses and institutional investors to get more involved without the fear of potentially breaking any rules. The Genius Act is a departure from the climate under the previous administration, when lawsuits and enforcement stifled crypto adoption. XRP's developer, Ripple Labs, was affected by this legal uncertainty. In 2021, Ripple lost its partnership with one of its highest-profile clients, MoneyGram, which stopped using its XRP-based liquidity solutions after Ripple was sued by the Securities and Exchange Commission (SEC) over alleged securities law violations. The case has now been largely resolved with XRP not classified as a security when sold to retail investors, although there are still discussions about settling fines related to Ripple's sales of XRP to institutional investors. The path to real-world utility XRP's main selling point is its focus on real-world utility. Instead of trying to be a platform for highly speculative and often useless decentralized applications (dApps), XRP focuses on the more tangible market for international payments. Its speed and low fees (0.00001 XRP per transaction) make it an ideal bridge between different currencies. For example, if someone in the U.S. wanted to send money to Japan, they could buy XRP with dollars and use that XRP to buy Japanese yen, bypassing slow and potentially costly intermediaries. Dollar-pegged stablecoins promise to make this process even easier by removing the volatility inherent in a free-floating bridge currency like XRP. Instead of allowing its niche to be disrupted, XRP's developers are joining the fray. In 2024, they launched a dollar-pegged stablecoin of their own called RLUSD. Consumer use of RLUSD can indirectly benefit XRP because both tokens are built on the same network. RLUSD transaction fees are paid with XRP, which is then removed from circulation (burned). Is it too late to buy XRP? Despite its relatively small unit price of just $3.15 at the time of this writing, XRP is the third-largest cryptocurrency, with a market cap of $187 billion. While this vast size gives it more brand recognition and stability, it also means that investors shouldn't expect a repeat of the explosive returns XRP enjoyed in the past. That said, slow and steady often wins the race. XRP has graduated from the boom and bust volatility of a meme coin, and investors should focus on its long-term growth potential as it benefits from easing regulatory pressure and compelling real-world use cases. Will Ebiefung has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends XRP. The Motley Fool has a disclosure policy. The Motley Fool is a USA TODAY content partner offering financial news, analysis and commentary designed to help people take control of their financial lives. Its content is produced independently of USA TODAY. Should you invest $1,000 in XRP right now? Offer from the Motley Fool: Before you buy stock in XRP, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and XRP wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks »
Yahoo
35 minutes ago
- Yahoo
Wells Fargo (NYSE:WFC) Will Pay A Larger Dividend Than Last Year At $0.45
Wells Fargo & Company's (NYSE:WFC) dividend will be increasing from last year's payment of the same period to $0.45 on 1st of September. Although the dividend is now higher, the yield is only 2.3%, which is below the industry average. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Wells Fargo's Dividend Forecasted To Be Well Covered By Earnings While yield is important, another factor to consider about a company's dividend is whether the current payout levels are feasible. Wells Fargo has established itself as a dividend paying company with over 10 years history of distributing earnings to shareholders. Based on Wells Fargo's last earnings report, the payout ratio is at a decent 27%, meaning that the company is able to pay out its dividend with a bit of room to spare. Looking forward, EPS is forecast to rise by 24.4% over the next 3 years. The future payout ratio could be 30% over that time period, according to analyst estimates, which is a good look for the future of the dividend. View our latest analysis for Wells Fargo Dividend Volatility The company's dividend history has been marked by instability, with at least one cut in the last 10 years. The annual payment during the last 10 years was $1.40 in 2015, and the most recent fiscal year payment was $1.80. This works out to be a compound annual growth rate (CAGR) of approximately 2.5% a year over that time. We're glad to see the dividend has risen, but with a limited rate of growth and fluctuations in the payments the total shareholder return may be limited. The Dividend Looks Likely To Grow With a relatively unstable dividend, it's even more important to evaluate if earnings per share is growing, which could point to a growing dividend in the future. Wells Fargo has seen EPS rising for the last five years, at 56% per annum. A low payout ratio gives the company a lot of flexibility, and growing earnings also make it very easy for it to grow the dividend. We Really Like Wells Fargo's Dividend In summary, it is always positive to see the dividend being increased, and we are particularly pleased with its overall sustainability. Earnings are easily covering distributions, and the company is generating plenty of cash. All of these factors considered, we think this has solid potential as a dividend stock. Market movements attest to how highly valued a consistent dividend policy is compared to one which is more unpredictable. Meanwhile, despite the importance of dividend payments, they are not the only factors our readers should know when assessing a company. For example, we've picked out 1 warning sign for Wells Fargo that investors should know about before committing capital to this stock. Is Wells Fargo not quite the opportunity you were looking for? Why not check out our selection of top dividend stocks. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
